Results 1 to 10 of about 100,615 (218)
Levosimendan in lung transplant recipients on VA‑ECMO
Chronic heart failure is one of the most dreadful complications in the early postoperative period following lung transplantation. At the same time, the effect of using levosimendan in the early post-lung transplant period is currently insignificant and ...
S. V. Zhuravel +4 more
doaj +1 more source
Biomimetic electromechanical stimulation to maintain adult myocardial slices in vitro
Cultured adult cardiac tissue undergoes rapid dedifferentiation, which hinders chronic in vitro studies. Here the authors investigate biomimetic electromechanical stimulation of adult myocardial slices applying different preload conditions, identifying ...
Samuel A. Watson +11 more
doaj +1 more source
Background We discovered a novel human endogenous retrovirus (CT-RCC HERV-E) that was selectively expressed in most clear cell renal cell carcinomas (ccRCC) and served as a source of antigens for T cell-mediated killing. Here, we described the cloning of
Long Chen +17 more
doaj +1 more source
Background: The impact of continuous distribution on allocation of multiorgan transplantation (MOT) involving lungs remains unexplored. Here we characterize how continuous distribution has affected lung-involved MOT. Methods: We conducted a retrospective
Haoran Jiang, MS +11 more
doaj +1 more source
2015 ESC/ERS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION
The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC ...
Nazzareno Galiè +20 more
doaj +1 more source
Indications for Lung Transplantation and Patient Selection
Globally, thousands of patients undergo lung transplantation owing to end-stage lung disease each year. As lung transplantation evolves, recommendations and indications are constantly being updated. In 2021, the International Society for Heart and Lung
Joohyung Son, Changwon Shin
doaj +1 more source
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
Although pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide, our understanding of the molecular mechanisms underlying this disease is still poor.
Ke-Qiong Deng +16 more
doaj +1 more source
Background Human dental mesenchymal stem cells (MSCs) are considered as highly accessible and attractive MSCs for use in regenerative medicine, yet some of their features are not as well characterized as other MSCs.
Victor G. Martinez +8 more
doaj +1 more source
Primary graft dysfunction prevention strategies in the perioperative period
Background: Primary graft dysfunction (PGD) remains a leading cause of early morbidity and mortality after heart and lung transplantation. It results from a multifactorial process involving ischemia–reperfusion injury, inflammatory and immune responses ...
Jérémie Guillemin, MD +5 more
doaj +1 more source
Single-Kidney Transplant on VA-ECMO While Recovering from Post-Heart-Transplant Graft Failure
Although no consensus exists on whether extracorporeal membrane oxygenation (ECMO) support is an indication for solid-organ transplantation other than heart and lung, this practice continues to be limited.
Gabriel Prada +3 more
doaj +1 more source

